Cargando…

Long non-coding RNA GAS5 inhibits DDP-resistance and tumor progression of epithelial ovarian cancer via GAS5-E2F4-PARP1-MAPK axis

BACKGROUND: Epithelial ovarian cancer (EOC) is the malignant tumor of the female reproductive system with the highest fatality rate. Tolerance of chemotherapeutic drugs like cisplatin (DDP) occurring in very early stage is one of the important factors of the poor prognosis of epithelial ovarian canc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Long, Xiaoran, Song, Keqi, Hu, Hao, Tian, Qi, Wang, Wenjing, Dong, Qian, Yin, Xia, Di, Wen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6686414/ https://www.ncbi.nlm.nih.gov/pubmed/31391118 http://dx.doi.org/10.1186/s13046-019-1329-2

Ejemplares similares

LncRNA GAS5 suppresses ovarian cancer progression by targeting the miR-96-5p/PTEN axis
por: Dong, Qian, et al.
Publicado: (2021)

Follicle-stimulating hormone promotes the proliferation of epithelial ovarian cancer cells by activating sphingosine kinase
por: Song, Keqi, et al.
Publicado: (2020)

DDP-resistant ovarian cancer cells-derived exosomal microRNA-30a-5p reduces the resistance of ovarian cancer cells to DDP
por: Liu, Ronghua, et al.
Publicado: (2020)

Retraction: DDP-resistant ovarian cancer cells-derived exosomal microRNA-30a-5p reduces the resistance of ovarian cancer cells to DDP
por: Liu, Ronghua, et al.
Publicado: (2021)

Expression of concern: DDP-resistant ovarian cancer cells-derived exosomal microRNA-30a-5p reduces the resistance of ovarian cancer cells to DDP
por: Liu, Ronghua, et al.
Publicado: (2021)

Long Non-Coding RNA GAS5 Targeting microRNA-21 to Suppress the Invasion and Epithelial–Mesenchymal Transition of Uveal Melanoma
por: Qi, Ying, et al.
Publicado: (2020)

Research Progress of Long Non-Coding RNA GAS5 in Malignant Tumors
por: Lin, Guohong, et al.
Publicado: (2022)

LncRNA GAS5-hnRNPK axis inhibited ovarian cancer progression via inhibition of AKT signaling in ovarian cancer cells
por: Zhang, Te, et al.
Publicado: (2023)

The role of long non-coding RNA GAS5 in cancers
por: Ji, Jiali, et al.
Publicado: (2019)

Long non-coding RNA GAS5 in human cancer
por: Yang, Xiaoyan, et al.
Publicado: (2020)

Sphingosine kinase 2 inhibitor ABC294640 displays anti-epithelial ovarian cancer activities in vitro and in vivo
por: Song, Keqi, et al.
Publicado: (2019)

GAS5 long non-coding RNA in malignant pleural mesothelioma
por: Renganathan, Arun, et al.
Publicado: (2014)

Long non-coding RNA GAS5 suppresses pancreatic cancer metastasis through modulating miR-32-5p/PTEN axis
por: Gao, Zhi-Qiang, et al.
Publicado: (2017)

Long noncoding RNA GAS5 attenuates cigarettesmoke-induced airway remodeling by regulatingmiR-217-5p/PTEN axis : GAS5 attenuates airway remodeling by miR-217-5p/PTEN axis
por: Du, Yong, et al.
Publicado: (2022)

The SRSF4–GAS5-Glucocorticoid Receptor Axis Regulates Ventricular Hypertrophy
por: Larrasa-Alonso, Javier, et al.
Publicado: (2021)

Adipocytes: active facilitators in epithelial ovarian cancer progression?
por: Dai, Lan, et al.
Publicado: (2020)

Altered expression of long non-coding RNA GAS5 in digestive tumors
por: Lu, Shounan, et al.
Publicado: (2019)

Long non-coding RNA GAS5 expression in patients with Down syndrome
por: Salemi, Michele, et al.
Publicado: (2020)

Psorachromene Suppresses Oral Squamous Cell Carcinoma Progression by Inhibiting Long Non-coding RNA GAS5 Mediated Epithelial-Mesenchymal Transition
por: Wang, Tong-Hong, et al.
Publicado: (2019)

KLF5 Promotes Tumor Progression and Parp Inhibitor Resistance in Ovarian Cancer
por: Wu, Yong, et al.
Publicado: (2023)

Long Non-coding RNA GAS5 Worsens Coronary Atherosclerosis Through MicroRNA-194-3p/TXNIP Axis
por: Li, Yanbing, et al.
Publicado: (2021)

5-Aza-dC suppresses melanoma progression by inhibiting GAS5 hypermethylation
por: Zhang, Yang-Jie, et al.
Publicado: (2022)

LncRNA GAS5 suppresses ovarian cancer by inducing inflammasome formation
por: Li, Jie, et al.
Publicado: (2018)

lncRNA GAS5 suppression of the malignant phenotype of ovarian cancer via the miR-23a-WT1 axis
por: Zhou, Li, et al.
Publicado: (2023)

The Non-Coding RNA GAS5 and Its Role in Tumor Therapy-Induced Resistance
por: Lambrou, George I., et al.
Publicado: (2020)

Flammable gas safety code
por: CERN. Geneva
Publicado: (1996)

Circ_0031242 Silencing Mitigates the Progression and Drug Resistance in DDP-Resistant Hepatoma Cells by the miR-924/POU3F2 Axis
por: Fan, Wei, et al.
Publicado: (2021)

LncRNA GAS5 Suppresses Colorectal Cancer Progress by Target miR-21/LIFR Axis
por: Xie, Juan, et al.
Publicado: (2022)

Suppression of YAP by DDP disrupts colon tumor progression
por: Li, Kun, et al.
Publicado: (2018)

Suppression of YAP by DDP disrupts colon tumor progression
por: Li, Kun, et al.
Publicado: (2021)

Activation of SphK1 by adipocytes mediates epithelial ovarian cancer cell proliferation
por: Dai, Lan, et al.
Publicado: (2021)

Long Non-Coding RNA GAS5 Suppresses Tumor Progression and Enhances the Radiosensitivity of Prostate Cancer Through the miR-320a/RAB21 Axis
por: Ma, Xiulong, et al.
Publicado: (2020)

Circ_0078607 increases platinum drug sensitivity via miR-196b-5p/GAS7 axis in ovarian cancer
por: Dai, Cheng, et al.
Publicado: (2023)

The Therapeutic Effects of DDP/CD44-shRNA Nanoliposomes in AMF on Ovarian Cancer
por: Guo, Ting, et al.
Publicado: (2022)

The Biological Role and Translational Implications of the Long Non-Coding RNA GAS5 in Breast Cancer
por: Grossi, Ilaria, et al.
Publicado: (2023)

Long non-coding RNA GAS5 increases the radiosensitivity of A549 cells through interaction with the miR-21/PTEN/Akt axis
por: Chen, Li, et al.
Publicado: (2020)

Long non-coding RNA GAS5 promotes cisplatin-chemosensitivity of osteosarcoma cells via microRNA-26b-5p/TP53INP1 axis
por: Li, Guowei, et al.
Publicado: (2023)

Long non-coding RNA GAS5 contributes to the progression of nonalcoholic fatty liver disease by targeting the microRNA-29a-3p/NOTCH2 axis
por: Cui, Juanjuan, et al.
Publicado: (2022)

The Emerging Role of PARP Inhibitors in the Treatment of Epithelial Ovarian Cancer
por: Gien, Lilian T., et al.
Publicado: (2010)

PARP-1 may be involved in angiogenesis in epithelial ovarian cancer
por: Wei, Wei, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_s8crrugcqebb0uj8h6qmfo016c